Efficacy and Safety of Pregabalin Prolonged Release–Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized Study

INTRODUCTION: Currently available treatments for chronic lower back pain (CLBP) do not adequately address both nociceptive and neuropathic components of pain. We evaluated efficacy and safety of fixed-dose combination (FDC) of low-dose pregabalin prolonged release 75 mg–etoricoxib 60 mg to address b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeole, Amit B., Sree Ranga Lakshmi, G., Selvakumar, C. J., Goni, Vijay G., Nawal, C. L., Valya, Bhanoth J., Patel, Brijesh J., Patel, Rohit D., Pawar, Eknath D., Panigrahi, Ranajit, Kumar, Ashish Y., Shintre, Shrinivas S., Devkare, Prashant H., Dharmadhikari, Shruti K., Choudhari, Sanjay Y., Doshi, Maulik S., Mehta, Suyog C., Joglekar, Sadhna J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633919/
https://www.ncbi.nlm.nih.gov/pubmed/36224489
http://dx.doi.org/10.1007/s40122-022-00437-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633919/
https://www.ncbi.nlm.nih.gov/pubmed/36224489
http://dx.doi.org/10.1007/s40122-022-00437-2

Ejemplares similares